BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27003656)

  • 21. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
    Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Liu JY; Jin L; Zhao MY; Zhang X; Liu CB; Zhang YX; Li FJ; Zhou JM; Wang HJ; Li JC
    Clin Chem Lab Med; 2011 Oct; 49(10):1727-33. PubMed ID: 21671803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer.
    Qian JY; Mou SH; Liu CB
    Asian Pac J Cancer Prev; 2012; 13(5):1911-5. PubMed ID: 22901146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
    Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
    Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
    World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The application of surface-enhanced laser desorption/ionization-time of flight-mass spectrometry in diagnosing dysplasia and chronic atrophic gastric-carditis in population with high risk of gastric-cardia adenocarcinoma].
    Wang DC; Wang LD; Zheng S; Fan ZM; Li JL; Feng CW; Zhang YR; Liu B; Gao SS; He X
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):573-6. PubMed ID: 16194406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
    Tsunemi S; Nakanishi T; Fujita Y; Bouras G; Miyamoto Y; Miyamoto A; Nomura E; Takubo T; Tanigawa N
    Oncol Rep; 2010 Apr; 23(4):949-56. PubMed ID: 20204278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry].
    Wang YS; Shen J; Yu JK; Zhang L; Ma JL; You WC; Pan KF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):677-80. PubMed ID: 19175180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weak cation magnetic separation technology and MALDI-TOF-MS in screening serum protein markers in primary type I osteoporosis.
    Shi XL; Li CW; Liang BC; He KH; Li XY
    Genet Mol Res; 2015 Nov; 14(4):15285-94. PubMed ID: 26634492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression and clinical significance of serum protein among patients with clear-cell renal cell carcinoma.
    Nuerrula Y; Rexiati M; Liu Q; Wang YJ
    Cancer Biomark; 2015; 15(4):485-91. PubMed ID: 26406868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.
    Umemura H; Togawa A; Sogawa K; Satoh M; Mogushi K; Nishimura M; Matsushita K; Tanaka H; Takizawa H; Kodera Y; Nomura F
    J Gastroenterol; 2011 May; 46(5):577-85. PubMed ID: 21298293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
    Liu C; Pan C; Shen J; Wang H; Yong L
    Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of serum peptidome patterns of esophageal squamous cell carcinoma patients for comprehensive treatment.
    Wan QL; Hou XS; Zhao G
    Asian Pac J Cancer Prev; 2013; 14(5):2919-23. PubMed ID: 23803054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of MALDI-TOF/MS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancer.
    Padoan A; Seraglia R; Basso D; Fogar P; Sperti C; Moz S; Greco E; Marchet A; de Manzoni G; Zambon CF; Navaglia F; Cristadoro L; Di Chiara A; Nitti D; Pedrazzoli S; Pavanello G; Plebani M
    Pancreas; 2013 May; 42(4):622-32. PubMed ID: 23271396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
    Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
    Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression.
    Malik G; Rojahn E; Ward MD; Gretzer MB; Partin AW; Semmes OJ; Veltri RW
    Prostate; 2007 Oct; 67(14):1565-75. PubMed ID: 17705230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening and identification analysis of serum protein biomarkers in nephroblastoma].
    Wang JX; Yang SB; Liu QL; Dong R; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1259-63. PubMed ID: 19595180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new tumor biomarker, serum protein peak at 3,144 m/z, in patients with node-positive breast cancer.
    Chen Z; Xu S; Su D; Liu W; Yang H; Xie S; Meng X; Lei L; Wang X
    Clin Transl Oncol; 2015 Jun; 17(6):486-94. PubMed ID: 25511546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel serum biomarkers for gastric cancer by magnetic bead.
    Liu W; Gao X; Cai Q; Li J; Zhu Z; Li C; Yao X; Yang Q; Xiang M; Yan M; Zhu Z
    Front Biosci (Elite Ed); 2010 Jun; 2(3):961-71. PubMed ID: 20515767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.